Bepirovirsen induces innate immune proteins independent of HBV

Hepatology International · Published 2026-08-04 · DOI 10.1007/s12072-026-11134-z

Free full text

Authors (16)

Jared L. Delahaye, Shihyun You, Kai Fu, Scott Van Buren, Cheng Zhu, William Jordan, Avijit Ray, Johannes M. Freudenberg, Kristen M. Consalvo, Luca Pagliaroli, Sohil Joshi, Puneet Dhawan, Dickens Theodore, Melanie Paff, Jill Walker, Jennifer M. Singh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Delahaye, J., You, S., Fu, K., et al. (2026). Bepirovirsen induces innate immune proteins independent of HBV. Hepatology International. https://doi.org/10.1007/s12072-026-11134-z

Related articles

• Bepirovirsen induces innate immune activation in the liver potentially through TLR8 signaling · JHEP Reports · 2026 · Cites or is cited by this article
• Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing · Journal of the Royal Statistical Society. Series B, Statistical methodology · 1995 · Cites or is cited by this article
• Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease · Hepatology International · 2026 · Same journal
• APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update · Hepatology International · 2026 · Same journal
• APASL STC on Wilson Disease; New Delhi 2026 · Hepatology International · 2026 · Same journal
• Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial · Hepatology International · 2026 · Same journal
• Phosphatidylethanol versus clinical criteria to diagnose alcohol use relapse after liver transplantation: a prospective cohort study · Hepatology International · 2026 · Same journal
• Precision medicine for G-CSF in ACLF: the biomarker gap · Hepatology International · 2026 · Same journal
• Response to letter to editor—Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon · Hepatology International · 2026 · Same journal
• Methodological Considerations in the MAFLD-MASLD Dichotomy for Cardiac Risk Assessment · Hepatology International · 2026 · Same journal